BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 356 filers reported holding BIONTECH SE in Q4 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $6,585 | +0.7% | 60,613 | 0.0% | 0.00% | 0.0% |
Q2 2023 | $6,542 | -13.8% | 60,613 | -0.5% | 0.00% | 0.0% |
Q1 2023 | $7,588 | -93.6% | 60,913 | -92.2% | 0.00% | -94.7% |
Q4 2022 | $117,814 | -99.9% | 784,278 | -37.6% | 0.02% | -32.1% |
Q3 2022 | $169,451,000 | -38.5% | 1,256,309 | -32.0% | 0.03% | -20.0% |
Q2 2022 | $275,527,000 | +5.8% | 1,847,935 | +21.0% | 0.04% | +34.6% |
Q1 2022 | $260,415,000 | -34.3% | 1,526,825 | -0.7% | 0.03% | -27.8% |
Q4 2021 | $396,425,000 | +24.8% | 1,537,723 | +32.1% | 0.04% | +20.0% |
Q3 2021 | $317,716,000 | -30.1% | 1,163,839 | -42.7% | 0.03% | -28.6% |
Q2 2021 | $454,624,000 | +100.7% | 2,030,661 | -2.1% | 0.04% | +82.6% |
Q1 2021 | $226,559,000 | +76.5% | 2,074,906 | +31.8% | 0.02% | +76.9% |
Q4 2020 | $128,379,000 | +54.8% | 1,574,821 | +31.5% | 0.01% | +30.0% |
Q3 2020 | $82,913,000 | +318.3% | 1,197,644 | +303.2% | 0.01% | +400.0% |
Q2 2020 | $19,822,000 | – | 297,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
Systrade AG | 50,000 | $5,432,000 | 4.70% |
Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
AtonRa Partners | 4,707 | $511,368 | 1.07% |
Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |